TLR4 and Fabry disease: Furthermore, it has been shown that in FD patients, GL3 is recognized as an antigen by invariant NKT (iNKT) cells, binding Toll-Like receptor 4 (TLR4), and is presented by the class I major histocompatibility complex CD1d receptor.